Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Impact of the 1000 genomes project on the next wave of pharmacogenomic discovery.

Pharmacogenomics - 1 Feb 2010

Zhang Wei, Dolan M Eileen

Abstract excerpt

The 1000 Genomes Project aims to provide detailed genetic variation data on over 1000 genomes from worldwide populations using the next-generation sequencing technologies. Some of the samples utilized for the 1000 Genomes Project are the International HapMap samples that are composed of lymphoblastoid cell lines derived from individuals of different world populations. These same samples have been used in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Base Sequence
Share to Drug Discovery
Share to Drug Therapy

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genetic Variation

Share to Genome, Human

Share to Pharmacogenetics

Source

Open in PubMed Open full text

Identifiers

PMID: 20136363
DOI: 10.2217/pgs.09.173
PMCID: PMC2833269

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Impact of the 1000 genomes project on the next wave of pharmacogenomic discovery.PMID 20136363Read ↗

Whole genome sequencing in pharmacogenomicsSemantic proximity Read ↗

Approaches to the discovery of pharmacogenomic markers in oncology: 2000-2010-2020.Semantic proximity Read ↗

Identifying genetic variants that contribute to chemotherapy-induced cytotoxicity.Semantic proximity Read ↗

Pharmacogenetics and pharmacogenomics of anticancer agents.Semantic proximity Read ↗

A pharmacogene database enhanced by the 1000 Genomes Project.Semantic proximity Read ↗

A genome-wide approach to identify genetic variants that contribute to etoposide-induced cytotoxicity.Semantic proximity Read ↗

Targeted Next-Generation Sequencing for Comprehensive Genetic Profiling of Pharmacogenes.Semantic proximity Read ↗

Pharmacogenomic Characterization of US FDA-approved Cytotoxic DrugsSemantic proximity Read ↗

Genome-wide association studies of drug response and toxicity: an opportunity for genome medicine.Semantic proximity Read ↗

The Role of Next-Generation Sequencing in Pharmacogenetics and Pharmacogenomics.Semantic proximity Read ↗

Use of pharmacogenetics for predicting cancer prognosis and treatment exposure, response and toxicity.Semantic proximity Read ↗

Advances in pharmacogenomic research and development.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.